225 related articles for article (PubMed ID: 27374978)
1. MAPT haplotype diversity in multiple system atrophy.
Labbé C; Heckman MG; Lorenzo-Betancor O; Murray ME; Ogaki K; Soto-Ortolaza AI; Walton RL; Fujioka S; Koga S; Uitti RJ; van Gerpen JA; Petersen RC; Graff-Radford NR; Younkin SG; Boeve BF; Cheshire WP; Low PA; Sandroni P; Coon EA; Singer W; Wszolek ZK; Dickson DW; Ross OA
Parkinsonism Relat Disord; 2016 Sep; 30():40-5. PubMed ID: 27374978
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
[TBL] [Abstract][Full Text] [Related]
3. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
[TBL] [Abstract][Full Text] [Related]
4. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.
Labbé C; Ogaki K; Lorenzo-Betancor O; Soto-Ortolaza AI; Walton RL; Rayaprolu S; Fujioka S; Murray ME; Heckman MG; Puschmann A; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Sanotsky Y; Rektorová I; McLean PJ; Rademakers R; Ertekin-Taner N; Hassan A; Ahlskog JE; Boeve BF; Petersen RC; Maraganore DM; Adler CH; Ferman TJ; Parisi JE; Graff-Radford NR; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA
Neurology; 2015 Nov; 85(19):1680-6. PubMed ID: 26333800
[TBL] [Abstract][Full Text] [Related]
5. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
[TBL] [Abstract][Full Text] [Related]
6. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
[TBL] [Abstract][Full Text] [Related]
8. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
[TBL] [Abstract][Full Text] [Related]
9. MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.
Valentino RR; Scotton WJ; Roemer SF; Lashley T; Heckman MG; Shoai M; Martinez-Carrasco A; Tamvaka N; Walton RL; Baker MC; Macpherson HL; Real R; Soto-Beasley AI; Mok K; Revesz T; Christopher EA; DeTure M; Seeley WW; Lee EB; Frosch MP; Molina-Porcel L; Gefen T; Redding-Ochoa J; Ghetti B; Robinson AC; Kobylecki C; Rowe JB; Beach TG; Teich AF; Keith JL; Bodi I; Halliday GM; Gearing M; Arzberger T; Morris CM; White CL; Mechawar N; Boluda S; MacKenzie IR; McLean C; Cykowski MD; Wang SJ; Graff C; Nagra RM; Kovacs GG; Giaccone G; Neumann M; Ang LC; Carvalho A; Morris HR; Rademakers R; Hardy JA; Dickson DW; Rohrer JD; Ross OA;
Lancet Neurol; 2024 May; 23(5):487-499. PubMed ID: 38631765
[TBL] [Abstract][Full Text] [Related]
10. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
11. Association analysis of the GRN rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.
Chen Y; Cao B; Ou R; Chen X; Zhao B; Wei Q; Wu Y; Shang HF
Int J Neurosci; 2016 Oct; 126(10):947-54. PubMed ID: 26303052
[TBL] [Abstract][Full Text] [Related]
12. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
[TBL] [Abstract][Full Text] [Related]
13. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.
Labbé C; Heckman MG; Lorenzo-Betancor O; Soto-Ortolaza AI; Walton RL; Murray ME; Allen M; Uitti RJ; Wszolek ZK; Smith GE; Kantarci K; Knopman DS; Lowe VJ; Jack CR; Ertekin-Taner N; Hassan A; Savica R; Petersen RC; Parisi JE; Maraganore DM; Graff-Radford NR; Ferman TJ; Boeve BF; Dickson DW; Ross OA
Alzheimers Dement; 2016 Dec; 12(12):1297-1304. PubMed ID: 27287057
[TBL] [Abstract][Full Text] [Related]
14. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
[TBL] [Abstract][Full Text] [Related]
15. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
16. The alpha-synuclein gene in multiple system atrophy.
Ozawa T; Healy DG; Abou-Sleiman PM; Ahmadi KR; Quinn N; Lees AJ; Shaw K; Wullner U; Berciano J; Moller JC; Kamm C; Burk K; Josephs KA; Barone P; Tolosa E; Goldstein DB; Wenning G; Geser F; Holton JL; Gasser T; Revesz T; Wood NW;
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):464-7. PubMed ID: 16543523
[TBL] [Abstract][Full Text] [Related]
17. Cross-examining candidate genes implicated in multiple system atrophy.
Katzeff JS; Phan K; Purushothuman S; Halliday GM; Kim WS
Acta Neuropathol Commun; 2019 Jul; 7(1):117. PubMed ID: 31340844
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy.
Al-Chalabi A; Dürr A; Wood NW; Parkinson MH; Camuzat A; Hulot JS; Morrison KE; Renton A; Sussmuth SD; Landwehrmeyer BG; Ludolph A; Agid Y; Brice A; Leigh PN; Bensimon G;
PLoS One; 2009 Sep; 4(9):e7114. PubMed ID: 19771175
[TBL] [Abstract][Full Text] [Related]
19. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
[TBL] [Abstract][Full Text] [Related]
20. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
